Filters
In patients with type 2 diabetes (T2D) and established atherosclerotic cardiovascular disease (ASCVD), subcutaneous (SC) semaglutide Q1W was associated with lower risks of 3-point and 5-point major adverse cardiovascular events (3P- and 5P-MACE) and all-cause mortality vs dulaglutide, according to the real-world REACH study presented at the European Association for the Study of Diabetes (EASD) 2025 Annual Meeting.
Lowering the systolic blood pressure (SBP) target to <120 mm Hg compared with <140 mm Hg has a beneficial effect on retinal microvasculature among hypertensive patients with high cardiovascular risk, suggests a recent study.
In patients with type 2 diabetes (T2D), use of sodium-glucose cotransporter 2 inhibitors (SGLT2i) is associated with a 36 percent reduction in risk of atherothrombotic major adverse cardiovascular events (MACE) vs dipeptidyl peptidase-4 inhibitors (DPP4i), a recent real-world territory-wide study in Hong Kong has shown.
Individuals with SARS‐CoV‐2 infection, especially those who are hospitalized, face long‐term declines in left ventricular ejection fraction (LVEF), according to a retrospective study.
Older adults with frailty are predisposed to atrial fibrillation (AF)-related hospitalizations, regardless of the presence of multimorbidity, according to a study.
Individuals exposed to brighter lights at night have increased risks of incident coronary artery disease, myocardial infarction, heart failure, atrial fibrillation, and stroke, according to a study.
The reduction in relative risk with intensive vs standard systolic blood pressure (SBP) treatment among individuals without baseline cardiovascular disease (CVD) is consistent across the risk strata using the PREVENT* equations, as shown in the SPRINT study.
Individuals who sustained an acute dengue virus infection are predisposed to cardiovascular events up to 30 days after infection, although the excess risk was modest, according to a study from Singapore.
Timing of surgery appears to influence long-term outcomes in asymptomatic severe mitral regurgitation, such that performing the surgery early leads to better results over the long term than waiting until symptoms develop, according to a study.
Prolonged dual antiplatelet therapy (DAPT) duration appears to lower the risk of cardiac death and myocardial infarction, but may increase the risk of minor bleeding, in patients undergoing chronic total occlusion percutaneous coronary intervention, reports a recent study.
